Niclas S. Rasmussen
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
A cluster of type II interferon-regulated genes associates with disease activity in patients with systemic lupus erythematosus.
Journal: Journal of autoimmunity
Published: May 25, 2022
Human herpesvirus infections and circulating microvesicles expressing galectin-3 binding protein in patients with systemic lupus erythematosus.
Journal: Clinical and experimental rheumatology
Published: June 07, 2021
Microvesicles in active lupus nephritis show Toll-like receptor 9-dependent co-expression of galectin-3 binding protein and double-stranded DNA.
Journal: Clinical and experimental immunology
Published: August 06, 2020
Galectin-3-binding protein is a novel predictor of venous thromboembolism in systemic lupus erythematosus.
Journal: Clinical and experimental rheumatology
Published: August 03, 2020
Erythrocytes restrict microvesicle-induced production of reactive oxygen species by polymorphonuclear leukocytes.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: January 23, 2019
Stimulation of Mononuclear Cells Through Toll-Like Receptor 9 Induces Release of Microvesicles Expressing Double-Stranded DNA and Galectin 3-Binding Protein in an Interferon-α-Dependent Manner.
Journal: Frontiers in immunology
Published: December 15, 2018
Microparticles - culprits in the pathogenesis of systemic lupus erythematosus?
Journal: Expert review of clinical immunology
Published: May 08, 2018
Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.
Journal: PloS one
Published: May 29, 2017
A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus.
Journal: Clinical proteomics
Published: November 25, 2016
"Kill" the messenger: Targeting of cell-derived microparticles in lupus nephritis.
Journal: Autoimmunity reviews
Published: February 26, 2016
Safe and effective tumour necrosis factor-α inhibitor (etanercept) treatment of chronic episodic arthritis in a patient with cystic fibrosis.
Journal: Scandinavian journal of rheumatology
Published: January 21, 2016
Last Updated: 09/26/2026